GOSSAMER BIO INC's ticker is GOSS and the CUSIP is 38341P102. A total of 97 filers reported holding GOSSAMER BIO INC in Q3 2023. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $499 | +38.6% | 600 | +100.0% | 0.00% | – |
| Q2 2023 | $360 | -66.6% | 300 | -64.9% | 0.00% | – |
| Q1 2023 | $1,077 | -46.2% | 855 | +28.4% | 0.00% | – |
| Q4 2022 | $2,000 | -60.0% | 666 | +93.6% | 0.00% | – |
| Q3 2022 | $5,000 | +66.7% | 344 | 0.0% | 0.00% | – |
| Q2 2022 | $3,000 | -88.5% | 344 | -88.5% | 0.00% | – |
| Q1 2022 | $26,000 | -42.2% | 2,994 | -24.6% | 0.00% | – |
| Q4 2021 | $45,000 | -13.5% | 3,972 | -4.7% | 0.00% | – |
| Q3 2021 | $52,000 | +79.3% | 4,167 | +16.8% | 0.00% | – |
| Q2 2021 | $29,000 | +163.6% | 3,567 | +193.1% | 0.00% | – |
| Q1 2021 | $11,000 | -8.3% | 1,217 | -1.3% | 0.00% | – |
| Q4 2020 | $12,000 | -29.4% | 1,233 | -14.0% | 0.00% | – |
| Q3 2020 | $17,000 | +41.7% | 1,433 | +53.6% | 0.00% | – |
| Q2 2020 | $12,000 | +33.3% | 933 | +1.6% | 0.00% | – |
| Q1 2020 | $9,000 | – | 918 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 8,055,916 | $6,708,967 | 4.36% |
| Velan Capital Investment Management LP | 3,065,136 | $2,552,645 | 2.06% |
| Monashee Investment Management LLC | 5,304,212 | $4,417,348 | 1.84% |
| CVI Holdings, LLC | 976,108 | $812,903 | 1.61% |
| Samsara BioCapital, LLC | 6,130,268 | $5,105,287 | 1.56% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 6,130,268 | $5,105,287 | 1.55% |
| Opaleye Management Inc. | 4,754,200 | $3,959,298 | 1.29% |
| Octagon Capital Advisors LP | 8,187,883 | $6,818,869 | 1.05% |
| NEA Management Company, LLC | 15,727,942 | $13,098,230 | 1.01% |
| GREAT POINT PARTNERS LLC | 6,230,272 | $5,188,571 | 0.94% |